Bispecific T-cell engagers in oral cancer immunotherapy

Bispecific T-cell engagers in oral cancer immunotherapy

Saved in:

Bibliographic Details
Main Author:	Veeraraghavan Vishnu Priya
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024001018
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Insights of nano drug delivery for cancer immunotherapy: Targeting tumor-associated macrophages in oral squamous cell carcinoma
by: Kalaiselvi Krishnamoorthy, et al.
Published: (2024-06-01)

Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
by: Amelia C. McCue, et al.
Published: (2024-12-01)

Immunonutrition: A paradigm shift in oral cancer management
by: Vishnu Priya Veeraraghavan
Published: (2024-06-01)

Promoting oral cancer awareness in LGBTQ+ communities - Diversity in oral health
by: Gayathri Rengasamy, et al.
Published: (2024-09-01)

Exploring the potential of bioluminescence in oral cancer
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-03-01)

Exosome mediated tailored therapy for oral cancer
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

Nanoengineered chemotherapy - A novel therapeutic strategy in oral cancer
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

CD44: From diagnosis to therapy in the journey of oral cancer
by: Selvaraj Jayaraman, et al.
Published: (2024-06-01)

NGS revolutionizing oral cancer: From genetic profiling to personalized therapy
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
by: Rahul Navab, et al.
Published: (2025-01-01)

Environmental pollution and its link to heightened oral cancer risk: A rapidly growing public health issue
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-06-01)

Emerging therapeutic targets in oral squamous cell carcinoma: Insights from genetic alterations
by: Santosh R. Patil, et al.
Published: (2024-06-01)

Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation
by: Oana Hangiu, et al.
Published: (2025-01-01)

Natural killer cell engagers for cancer immunotherapy
by: Shahryar Khoshtinat Nikkhoi, et al.
Published: (2025-01-01)

Can vimentin be an emerging early detection molecular biomarker in oral squamous cell carcinoma?
by: Kalaiselvi Krishnamoorthy, et al.
Published: (2024-06-01)

Exploring the Nanopore principle based portable device in oral cancer can serve as potential diagnostic tool facilitating focused treatment
by: Arthisri Anandhi Sekar, et al.
Published: (2024-03-01)

CDK5RAP2: A potential prognostication biomarker for oral squamous cell carcinoma?
by: Benson Paul, et al.
Published: (2024-06-01)

Revolutionizing precision medicine in oral squamous cell carcinoma: Harnessing 3D in vitro models for translation
by: Nitesh Buldak, et al.
Published: (2024-09-01)

Advancements in targeted drug delivery: A promising approach in oral cancer treatment
by: Rajkumar Prabhakaran, et al.
Published: (2024-06-01)

Nuclear factor Erythroid 2-related factor (Nrf2): A potential therapeutic target for oral cancer - Molecular insights
by: Kaviyarasi Renu, et al.
Published: (2024-06-01)

Oncolytic virotherapy in head and neck cancer: A hope?
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-03-01)

“Comment on the “the impact of emotional distress on suicidal ideation in head and neck cancer patients: A review”
by: Gayathri Rengasamy, et al.
Published: (2024-09-01)

Perspective on enhancing quality of life in oral cancer patients: Integrative approaches and comprehensive care
by: Sohaib Arshad, et al.
Published: (2024-09-01)

Revolutionizing oral cancer research with 3D bioprinting technology
by: Bharati R. Doni, et al.
Published: (2024-06-01)

Immunotherapy in oral cancer treatment: Harnessing the immune system to combat oral squamous cell carcinoma
by: Santosh R. Patil
Published: (2024-06-01)

Targeted therapy: Role of liposome-based drug delivery in advancing oral cancer treatment
by: Meenakshi Sundari Rajendran, et al.
Published: (2024-06-01)

Osteopontin in oral squamous cell carcinoma: A multifaceted player in tumor development and prognosis
by: Hema Suryawanshi, et al.
Published: (2024-06-01)

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01)

A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
by: Gerhard Frey, et al.
Published: (2024-12-01)

Targeting autophagy to enhance chemotherapy and immunotherapy in oral cancer
by: Xiaoli Zeng, et al.
Published: (2025-01-01)

Advancements in immunotherapy: Transforming the landscape of oral cancer treatment
by: Madhan Krishnan, et al.
Published: (2024-09-01)

Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
by: Methi Wathikthinnakon, et al.
Published: (2022-04-01)

New bispecific antibodies in diffuse large B-cell lymphoma
by: Adrian G. Minson, et al.
Published: (2025-02-01)

Deciphering genomic complexity: Understanding intratumor heterogeneity, clonal evolution, and therapeutic vulnerabilities in oral squamous cell carcinoma
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-06-01)

Prodrug-based bispecific antibodies for cancer therapy: advances and future directions
by: Zhijuan Ai, et al.
Published: (2025-01-01)

Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
by: Methi Wathikthinnakon, et al.
Published: (2025-02-01)

Oral metastasis of clear cell renal carcinoma treated with immunotherapy
by: Camila Alves Ferri, et al.
Published: (2024-03-01)

A pivotal decade for bispecific antibodies?
by: Marlena Surowka, et al.
Published: (2024-12-01)

Developability considerations for bispecific and multispecific antibodies
by: Alaa Amash, et al.
Published: (2024-12-01)

Carbohydrate ligand engagement with CD11b enhances differentiation of tumor-associated myeloid cells for immunotherapy of solid cancers
by: Mei Zhang, et al.
Published: (2023-06-01)